ภาควิชากุมารเวชศาสตร์ | คณะแพทยศาสตร์ศิริราชพยาบาล มหาวิทยาลัยมหิดล

41.

Ngamprasertchai T.; Rattanaumpawan P.; Kaewkungwal J.; Phisalprapa P.; Chongtrakool P.; Kerdsin A.; Luvira V.; Thaipadungpanit J.; Kajeekul R.; Srisompong J.; Yincharoen P.; Chokephaibulkit K.; Lawpoolsri S.

Pneumococcal carriage among high-risk adults in a country with nonmandatory pneumococcal vaccination during the coronavirus disease 2019 pandemic
Journal of Infection and Public Health. 2023. 16 (7): 1102-1108.

42.

Chokephaibulkit K, Puthanakit T, Chaithongwongwatthana S, Bhat N, Tang Y, Anugulruengkitt S, Chayachinda C, Anuwutnavin S, Lapphra K, Rungmaitree S, Tawan M, Andi-Lolo I, Holt R, Fortuna L, Kerdsomboon C, Yuwaree V, Mansouri S, Thai PH, Innis BL.

A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women
Vaccine. 2023.

43.

Ngamprasertchai T.; Kositamongkol C.; Lawpoolsri S.; Rattanaumpawan P.; Luvira V.; Chongtrakool P.; Kaewkungwal J.; Chokephaibulkit K.; Phisalprapa P.

A cost-effectiveness analysis of the 13-valent pneumococcal conjugated vaccine and the 23-valent pneumococcal polysaccharide vaccine among Thai older adult
Frontiers in Public Health. 2023. 11

44.

Terada M, Nakamura K, Matsuda T, Okuma HS, Sudo K, Yusof A, Imasa M, Sirachainan E, Anh PT, Fujiwara Y, Yamamoto N, Voon PJ, Chokephaibulkit K, Shibata T, Inoue M, Mano H, Shimoi T, Sriuranpong V, Yonemori K, Shimada K.

A new era of the Asian clinical research network: a report from the ATLAS international symposium
Japanese Journal of Clinical Oncology. 2023. 53 (7): 619-628.

45.

Hart J.D.; Ong D.S.; Chokephaibulkit K.; Ong-Lim A.T.; Vereti I.; Crawford N.W.; Russell F.

Considerations for vaccinating children against COVID-19
BMJ Paediatrics Open. 2023. 7 (1):

46.

Chayachinda C, Watananirun K, Phatihattakorn C, Anuwutnavin S, Niyomnaitham S, Phongsamart W, Lapphra K, Wittawatmongkol O, Rungmaitree S, Jansarikit L, Boonnak K, Wongprompitak P, Senawong S, Upadhya A, Toh ZQ, Licciardi PV, Chokephaibulkit K.

Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women
Human Vaccines and Immunotherapeutics. 2023. 19 (2):

47.

Oey A.; McClure M.; Symons J.A.; Chanda S.; Fry J.; Smith P.F.; Luciani K.; Fayon M.; Chokephaibulkit K.; Uppala R.; Bernatoniene J.; Furuno K.; Stanley T.; Huntjens D.; Witek J.

Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results
PLoS ONE. 2023. 18 (7):

48.

Phongsamart W.; Allen K.E.; Vandepitte W.P.; Techasaensiri C.; Kosalaraksa P.; Laoprasopwattana K.; Khantee P.; Udompornwattana S.; Suwanpakdee D.; Sudjaritruk T.; Puthanakit T.; Anugulruengkitt S.; Southern J.; Fletcher M.A.; Dunne E.M.; Thamaree R.; Morales G.; Chokephaibulkit K.; Chotpitayasunondh T.

Outcomes among Thai children with risk conditions hospitalized for pneumococcal disease (invasive or non-bacteraemic pneumonia): A multi-centre, observational study
IJID Regions. 2023. 8 49-57.

49.

Licciardi P.V.; Chokephaibulkit K.; Satzke C.

Pneumococcal serosurveillance: one piece of the puzzle
The Lancet Infectious Diseases. 2023.

50.

Angkasekwinai N, Niyomnaitham S, Sewatanon J, Phumiamorn S, Sukapirom K, Senawong S, Toh ZQ, Umrod P, Somporn T, Chumpol S, Ritthitham K, Jantraphakorn Y, Srisutthisamphan K, Chokephaibulkit K, Chatchatee P.

The immunogenicity and reactogenicity of four COVID-19 booster vaccinations against SARS-CoV-2 variants following CoronaVac or ChAdOx1 nCoV-19 primary series
Asian Pac J Allergy Immunol. 2023.

ผลงานที่ได้รับการตีพิมพ์